163 related articles for article (PubMed ID: 15212803)
1. Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance.
Wolter DJ; Hanson ND; Lister PD
FEMS Microbiol Lett; 2004 Jul; 236(1):137-43. PubMed ID: 15212803
[TBL] [Abstract][Full Text] [Related]
2. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
[TBL] [Abstract][Full Text] [Related]
3. [The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa].
Yi MY; Wang PY; Huang HJ; Liu YC
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):457-62. PubMed ID: 16677571
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.
Wolter DJ; Smith-Moland E; Goering RV; Hanson ND; Lister PD
Diagn Microbiol Infect Dis; 2004 Sep; 50(1):43-50. PubMed ID: 15380277
[TBL] [Abstract][Full Text] [Related]
6. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan.
Sanbongi Y; Shimizu A; Suzuki T; Nagaso H; Ida T; Maebashi K; Gotoh N
Microbiol Immunol; 2009 Jul; 53(7):361-7. PubMed ID: 19563394
[TBL] [Abstract][Full Text] [Related]
7. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
[TBL] [Abstract][Full Text] [Related]
8. Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa.
Ikonomidis A; Tsakris A; Kantzanou M; Spanakis N; Maniatis AN; Pournaras S
FEMS Microbiol Lett; 2008 Feb; 279(1):36-9. PubMed ID: 18070070
[TBL] [Abstract][Full Text] [Related]
9. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates.
Naenna P; Noisumdaeng P; Pongpech P; Tribuddharat C
Southeast Asian J Trop Med Public Health; 2010 May; 41(3):614-24. PubMed ID: 20578550
[TBL] [Abstract][Full Text] [Related]
10. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Lee JY; Ko KS
Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
[TBL] [Abstract][Full Text] [Related]
11. Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem.
Farra A; Islam S; Strålfors A; Sörberg M; Wretlind B
Int J Antimicrob Agents; 2008 May; 31(5):427-33. PubMed ID: 18375104
[TBL] [Abstract][Full Text] [Related]
12. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.
Ocampo-Sosa AA; Cabot G; Rodríguez C; Roman E; Tubau F; Macia MD; Moya B; Zamorano L; Suárez C; Peña C; Domínguez MA; Moncalián G; Oliver A; Martínez-Martínez L;
Antimicrob Agents Chemother; 2012 Apr; 56(4):1703-13. PubMed ID: 22290967
[TBL] [Abstract][Full Text] [Related]
13. A copper-activated two-component system interacts with zinc and imipenem resistance in Pseudomonas aeruginosa.
Caille O; Rossier C; Perron K
J Bacteriol; 2007 Jul; 189(13):4561-8. PubMed ID: 17449606
[TBL] [Abstract][Full Text] [Related]
14. A novel insertion sequence, ISPA26, in oprD of Pseudomonas aeruginosa is associated with carbapenem resistance.
Evans JC; Segal H
Antimicrob Agents Chemother; 2007 Oct; 51(10):3776-7. PubMed ID: 17682099
[No Abstract] [Full Text] [Related]
15. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele.
Shu JC; Su LH; Chiu CH; Kuo AJ; Liu TP; Lee MH; Su IN; Wu TL
Microb Drug Resist; 2015 Apr; 21(2):149-57. PubMed ID: 25386722
[TBL] [Abstract][Full Text] [Related]
16. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S
J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
[TBL] [Abstract][Full Text] [Related]
17. Carbapenem resistance in clinical isolates of Pseudomonas aeruginosa.
Walsh F; Amyes SG
J Chemother; 2007 Aug; 19(4):376-81. PubMed ID: 17855180
[TBL] [Abstract][Full Text] [Related]
18. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
[TBL] [Abstract][Full Text] [Related]
19. OprD mutations and inactivation in imipenem-resistant Pseudomonas aeruginosa isolates from China.
Fang ZL; Zhang LY; Huang YM; Qing Y; Cao KY; Tian GB; Huang X
Infect Genet Evol; 2014 Jan; 21():124-8. PubMed ID: 24211415
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of carbapenem resistance in cephalosporin-susceptible Pseudomonas aeruginosa in China.
Zeng ZR; Wang WP; Huang M; Shi LN; Wang Y; Shao HF
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):268-70. PubMed ID: 24359931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
